Physician profile
Jeffrey C Davis
NPI 1538198189
$4,486.55
in general payments reported to CMS, 2019-2025
19 companies · $560 in 2025
The $560 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,684 · 2021: $84.10 · 2022: $30.56 · 2023: $112 · 2024: $15.31 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $3,613.79 | 2019 | |
| Osteoremedies, LLC | $166.12 | 2025 | Blastx, Xperience |
| Orthalign INC | $147.32 | 2025 | Orthalign Plus |
| Smith+Nephew, INC. | $144.35 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $113.55 | 2019-2023 | Mako |
| Ethicon US, LLC | $71.35 | 2021 | |
| Getinge USA Sales, LLC | $40.31 | 2025 | Maquet Powerled II |
| Heron Therapeutics, INC. | $29.78 | 2021-2023 | Zynrelef |
| Convatec INC. | $29.56 | 2022-2024 | |
| Conmed Corporation | $22.75 | 2025 | System 2450, Visiclear |
| Bioventus LLC | $20.10 | 2023 | L360 Thigh System |
| Vertex Pharmaceuticals Incorporated | $19.71 | 2025 | |
| Becton, Dickinson and Company | $19.59 | 2025 | Arista |
| Ferring Pharmaceuticals INC. | $16.31 | 2022 | |
| Amgen INC. | $16.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $15.76 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.